Forte Biosciences, Inc. Profile Avatar - Palmy Investing

Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas,…

Biotechnology
US, Dallas [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of FBRX's Analysis
CIK: 1419041 CUSIP: 34962G109 ISIN: US34962G1094 LEI: - UEI: -
Secondary Listings
FBRX has no secondary listings inside our databases.